DNAprint Genomics (DNAG)

[Bill H]

More News (PR NEWSWIRE) Nightline: Friday Night November 21, 2003 Will Air a Segment on D
A Testing And Its Dramatic Impact on Our Heritage
Nightline: Friday Night November 21, 2003 Will Air a Segment on DNA Testing And
ts Dramatic Impact on Our Heritage

SARASOTA, Fla., Nov. 21 /PRNewswire-FirstCall/ -- Nightline, airing on ABC
Friday night November 21, 2003, will discuss and review DNA testing and our
perception of our heritage and what we often call 'Race.' This dramatic
disclosure will feature interviews from Dr. Mark Shriver, Assistant Professor
of Anthropology and Genetics at Penn State University, Dr. Tony Frudakis,
Chief Scientific Officer at DNAPrint(TM) genomics, Inc.
(OTC Bulletin Board: DNAP), and Mr. Wayne Joseph. The show will explore DNA
testing and its potential impact on all of us. Watch Nightline, guaranteed to
make you think! Check a local ABC affiliate for times in other time zones, but
the show typically airs at 11:30 PM Eastern time, usually right after the
local news.

About DNAPrint(TM) genomics, Inc.
DNAPrint(TM) genomics Inc. was founded by a team of scientists with
research and commercial experience in high-level mathematical modeling,
programming and molecular genetics. The DNAWitness(TM) and the
ANCESTRYbyDNA(TM) analysis is a direct result of focused research by the DNAP
research and development team.
In addition, using proprietary human genome research methods, the Company
develops pharma-predictive tests for matching patients with drugs based on
their genetic constitution, discovers disease genes for the development of new
drugs and develops new forensic genomics and consumer genomics-testing
products. The Company is traded on the NASDAQ OTC Bulletin Board under the
ticker symbol: DNAP. For more information about the company, please visit
www.dnaprint.com .
For more information on our genealogical DNA derived test,
ANCESTRYbyDNA(TM) 2.0, visit us on-line at www.ancestrybydna.com , helping
everyone to understand their genetic heritage.

All statements in this press release that are not historical are
forward-looking statements within the meaning of Section 21E of the Securities
Exchange Act, as amended. Such statements are subject to risks and
uncertainties that could cause actual results to differ materially from those
projected, including, but not limited to, uncertainties relating to
technologies, product development, manufacturing, market acceptance, cost and
pricing of DNAPrint's(TM) products, dependence on collaborations and partners,
regulatory approvals, competition, intellectual property of others, and patent
protection and litigation. DNAPrint(TM) genomics, Inc. expressly disclaims any
obligation or undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change in
DNAPrint's(TM) expectations with regard thereto or any change in events,
conditions, or circumstances on which any such statements are based.

Media and Press Contacts
Richard Gabriel
DNAPrintTM genomics, Inc.
CEO/President
[phone]

SOURCE DNAPrint(TM) genomics, Inc.
-0- 11/21/2003
/CONTACT: Richard Gabriel, CEO and President of DNAPrint(TM) genomics,
[phone]/
/Web site: http://www.dnaprint.com /
(DNAP)

CO: DNAPrint(TM) genomics, Inc.; ABC
ST: Florida
IN: MTC OTC TVN HEA ENT
SU:
*** end of story ***